|Product name: ||Tamoxifen Citrate|
|CAS No.: ||54965-24-1|
Tamoxifen citrate is the trans-isomer of a triphenylethylene derivative. The pKa' is 8.85, the equilibrium solubility in water at 37°C is 0.5 mg/mL and in 0.02 N HCl at 37°C, it is 0.2 mg/mL.
Tamoxifen is used to treat recurrent metastatic breast cancer in women. It can also be used as an adjuvant treatment for post-operative metastasis of breast cancer to prevent recurrence. It is also used to treat ovarian cancer, endometrial cancer and endometriosis.
|Appearance ||White or almost white, crystalline powder.|
|Heavy metals ||≤0.001%|
|Loss on drying ||≤0.5%|
|Sulfated ash ||≤0.1%|
|Impurities D ||≤0.3%|
|Impurities F ||≤0.3%|
|Impurities H ||≤0.3%|
Packing and Storage
Preserve in well-closed, light-resistant containers.